{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "G309D"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "L347P"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "KDD (K219A/D362A/D384A)"
        }
      ]
    },
    {
      "Gene": "parkin",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "T240R"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "Q311X"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "T415N"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0005149"
  },
  "Experiment Method": [
    {
      "Assay Method": "Co-immunoprecipitation",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y dopaminergic cells",
        "Description": "Lysates from transfected human SH-SY5Y dopaminergic cells expressing N - terminal Myc - tagged parkin (Myc - parkin) and/or C - terminally HA - tagged PINK1 (PINK1 - HA) were used; also untransfected SH - SY5Y cells and human brain were used for detecting endogenous proteins."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Immunoprecipitation results showed interactions between PINK1 and parkin; PINK1 pathogenic mutations G309D, L347P and kinase - dead mutation KDD did not significantly affect the interaction; parkin T240R reduced the interaction, while parkin T415N and Q311X did not affect the interaction."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "No",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In vitro phosphorylation assay",
      "Material used": {
        "Material Source": "Purified proteins",
        "Material Name": "Affinity - purified FLAG - tagged wild - type or mutant PINK1 and Myc - tagged parkin",
        "Description": "These purified proteins were used for the in vitro phosphorylation assay."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "PINK1:G309D",
          "Conclusion": "Abnormal",
          "Molecular Effect": "abolish kinase activity to phosphorylate parkin",
          "Result Description": "PD - linked PINK1 pathogenic mutations G309D and L347P and kinase - dead PINK1 KDD mutation abolished the phosphorylation of parkin by PINK1 in vitro; wild - type PINK1 phosphorylated parkin in the presence of Ca²⁺."
        },
        {
          "Variant": "PINK1:L347P",
          "Conclusion": "Abnormal",
          "Molecular Effect": "abolish kinase activity to phosphorylate parkin",
          "Result Description": "As above"
        },
        {
          "Variant": "PINK1:KDD",
          "Conclusion": "Abnormal",
          "Molecular Effect": "abolish kinase activity to phosphorylate parkin",
          "Result Description": "As above"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "No",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In vivo phosphorylation assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH - SY5Y cells",
        "Description": "SH - SY5Y cells transfected with Myc - tagged parkin and wild - type or mutant PINK1 or vector - transfected control were used; also cells transfected with Myc - tagged parkin and vehicle, non - targeting (NT) siRNA or PINK1 siRNA were used."
      },
      "Readout type": "Quantitative (relative level of phosphorylation)",
      "Readout description": [
        {
          "Variant": "PINK1:G309D",
          "Conclusion": "Abnormal",
          "Molecular Effect": "abolish ability to promote in vivo parkin phosphorylation",
          "Result Description": "Overexpression of wild - type PINK1 increased both basal and rotenone - induced phosphorylation of parkin; PINK1 G309D, L347P and KDD mutations abolished this ability; rotenone - induced phosphorylation of parkin was reduced in PINK1 - depleted cells."
        },
        {
          "Variant": "PINK1:L347P",
          "Conclusion": "Abnormal",
          "Molecular Effect": "abolish ability to promote in vivo parkin phosphorylation",
          "Result Description": "As above"
        },
        {
          "Variant": "PINK1:KDD",
          "Conclusion": "Abnormal",
          "Molecular Effect": "abolish ability to promote in vivo parkin phosphorylation",
          "Result Description": "As above"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Data represent mean + SEM from three independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In vitro ubiquitination assay",
      "Material used": {
        "Material Source": "Purified proteins",
        "Material Name": "Affinity - purified FLAG - tagged IKKγ, non - phosphorylated parkin or PINK1 - phosphorylated parkin, E1, E2 (UbcH13/Uev1a) and ubiquitin",
        "Description": "These purified proteins were used for the in vitro ubiquitination assay."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "PINK1:G309D",
          "Conclusion": "Abnormal",
          "Molecular Effect": "abolish ability to enhance parkin - mediated IKKγ polyubiquitination",
          "Result Description": "Phosphorylation of parkin by PINK1 increased the E3 ligase activity of parkin for catalyzing IKKγ polyubiquitination; PINK1 G309D, L347P and KDD mutations abolished this effect."
        },
        {
          "Variant": "PINK1:L347P",
          "Conclusion": "Abnormal",
          "Molecular Effect": "abolish ability to enhance parkin - mediated IKKγ polyubiquitination",
          "Result Description": "As above"
        },
        {
          "Variant": "PINK1:KDD",
          "Conclusion": "Abnormal",
          "Molecular Effect": "abolish ability to enhance parkin - mediated IKKγ polyubiquitination",
          "Result Description": "As above"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "No",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In vivo ubiquitination assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH - SY5Y cells",
        "Description": "SH - SY5Y cells co - transfected with FLAG - tagged IKKγ, HA - tagged wild - type or mutant ubiquitin, and other indicated constructs were used; also cells transfected with FLAG - tagged IKKγ, Myc - tagged parkin and vehicle, NT - siRNA or PINK1 siRNA were used."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "PINK1:G309D",
          "Conclusion": "Abnormal",
          "Molecular Effect": "abolish ability to promote parkin - mediated IKKγ polyubiquitination",
          "Result Description": "Parkin - mediated IKKγ polyubiquitination was increased by co - expression of wild - type PINK1; PINK1 G309D, L347P and KDD mutations abolished this effect; parkin - mediated IKKγ polyubiquitination was reduced in PINK1 - depleted cells."
        },
        {
          "Variant": "PINK1:L347P",
          "Conclusion": "Abnormal",
          "Molecular Effect": "abolish ability to promote parkin - mediated IKKγ polyubiquitination",
          "Result Description": "As above"
        },
        {
          "Variant": "PINK1:KDD",
          "Conclusion": "Abnormal",
          "Molecular Effect": "abolish ability to promote parkin - mediated IKKγ polyubiquitination",
          "Result Description": "As above"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All experiments were replicated three times with similar results."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      }
    }
  ]
}